OTC Pharmaceuticals in Australia

Datamonitor's OTC Pharmaceuticals in Australia industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

* Contains an executive summary and data on value, volume and/or segmentation

* Provides textual analysis of OTC Pharmaceuticals in Australia’s recent performance and future prospects

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes a five-year forecast of OTC Pharmaceuticals in Australia

* The leading companies are profiled with supporting key financial metrics

* Supported by the key macroeconomic and demographic data affecting the market

Highlights

* Detailed information is included on market size, measured by both value and volume

* Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

* Market shares are covered by manufacturer and/or brand

* Also features market breakdown by distribution channel

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness).

For the purposes of this report, Asia-Pacific comprises Australia, China, India, Japan, Singapore, South Korea, and Taiwan.

[Fade out the market survey infos]

TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 7
Market definition 7
Research highlights 8
Market analysis 9
MARKET VALUE 10
MARKET SEGMENTATION I 11
MARKET SEGMENTATION II 12
MARKET SHARE 13
FIVE FORCES ANALYSIS 14
Summary 14
Buyer power 16
Supplier power 17
New entrants 18
Substitutes 19
Rivalry 20
LEADING COMPANIES 21
Cerebos Pacific Limited 21
Reckitt Benckiser Plc 25
Johnson & Johnson 30
MARKET DISTRIBUTION 35
MARKET FORECASTS 36
Market value forecast 36
MACROECONOMIC INDICATORS 37
APPENDIX 39
Methodology 39
Industry associations 40
Related Datamonitor research 40
Disclaimer 42
ABOUT DATAMONITOR 43
Premium Reports 43
Summary Reports 43
Datamonitor consulting 43

LIST OF TABLES
Table 1: Australia OTC pharmaceuticals market value: $ million, 2005–09 10
Table 2: Australia OTC pharmaceuticals market segmentation I:% share, by value, 2009 11
Table 3: Australia OTC pharmaceuticals market segmentation II: % share, by value, 2009 12
Table 4: Australia OTC pharmaceuticals market share: % share, by value, 2009 13
Table 5: Cerebos Pacific Limited: key facts 21
Table 6: Cerebos Pacific Limited: key financials ($) 22
Table 7: Cerebos Pacific Limited: key financials (Si$) 23
Table 8: Cerebos Pacific Limited: key financial ratios 23
Table 9: Reckitt Benckiser Plc: key facts 25
Table 10: Reckitt Benckiser Plc: key financials ($) 27
Table 11: Reckitt Benckiser Plc: key financials (£) 27
Table 12: Reckitt Benckiser Plc: key financial ratios 28
Table 13: Johnson & Johnson: key facts 30
Table 14: Johnson & Johnson: key financials ($) 32
Table 15: Johnson & Johnson: key financial ratios 33
Table 16: Australia OTC pharmaceuticals market distribution: % share, by value, 2009 35
Table 17: Australia OTC pharmaceuticals market value forecast: $ million, 2009–14 36
Table 18: Australia size of population (million), 2005–09 37
Table 19: Australia gdp (constant 2000 prices, $ billion), 2005–09 37
Table 20: Australia gdp (current prices, $ billion), 2005–09 37
Table 21: Australia inflation, 2005–09 38
Table 22: Australia consumer price index (absolute), 2005–09 38
Table 23: Australia exchange rate, 2005–09 38

LIST OF FIGURES
Figure 1: Australia OTC pharmaceuticals market value: $ million, 2005–09 10
Figure 2: Australia OTC pharmaceuticals market segmentation I:% share, by value, 2009 11
Figure 3: Australia OTC pharmaceuticals market segmentation II: % share, by value, 2009 12
Figure 4: Australia OTC pharmaceuticals market share: % share, by value, 2009 13
Figure 5: Forces driving competition in the OTC pharmaceuticals market in Australia, 2009 14
Figure 6: Drivers of buyer power in the OTC pharmaceuticals market in Australia, 2009 16
Figure 7: Drivers of supplier power in the OTC pharmaceuticals market in Australia, 2009 17
Figure 8: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Australia, 2009 18
Figure 9: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Australia, 2009 19
Figure 10: Drivers of degree of rivalry in the OTC pharmaceuticals market in Australia, 2009 20
Figure 11: Cerebos Pacific Limited: revenues & profitability 24
Figure 12: Cerebos Pacific Limited: assets & liabilities 24
Figure 13: Reckitt Benckiser Plc: revenues & profitability 28
Figure 14: Reckitt Benckiser Plc: assets & liabilities 29
Figure 15: Johnson & Johnson: revenues & profitability 33
Figure 16: Johnson & Johnson: assets & liabilities 34
Figure 17: Australia OTC pharmaceuticals market distribution: % share, by value, 2009 35
Figure 18: Australia OTC pharmaceuticals market value forecast: $ million, 2009–14 36


[Fade out table of contents]